Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO
Sostelly, Alexandre, Henin, Emilie, Chauvenet, Laure, Hardy-Bessard, Anne-Claire, Jestin-Le Tallec, Véronique, Kirsher, Sylvie, Leyronnas, Cécile, Ligeza-Poisson, Catherine, Ramdane, Soraya, Salavt, Jacques, Van-Hult, Sylvie, Vannetzel, Jean-Michel, Freyer, Gilles, Tod, Michel, Falandry, Claire
Published in Journal of geriatric oncology (01.01.2013)
Published in Journal of geriatric oncology (01.01.2013)
Get full text
Journal Article